Fulgent Cash And Short Term Investments from 2010 to 2024
| FLGT Stock | USD 19.81 0.56 2.75% |
Cash And Short Term Investments | First Reported 2015-12-31 | Previous Quarter 424.2 M | Current Value 305.7 M | Quarterly Volatility 341.1 M |
Check Fulgent Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fulgent Genetics' main balance sheet or income statement drivers, such as Discontinued Operations of 49.5 K, Depreciation And Amortization of 33.3 M or Interest Expense of 38.9 M, as well as many indicators such as Price To Sales Ratio of 2.83, Dividend Yield of 0.018 or PTB Ratio of 0.72. Fulgent financial statements analysis is a perfect complement when working with Fulgent Genetics Valuation or Volatility modules.
Fulgent | Cash And Short Term Investments |
Latest Fulgent Genetics' Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Fulgent Genetics over the last few years. Short Term Investments is an account in the current assets section of Fulgent Genetics balance sheet. This account contains Fulgent Genetics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Fulgent Genetics fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Fulgent Genetics' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fulgent Genetics' overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Fulgent Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 210,248,861 | |
| Geometric Mean | 12,077,955 | |
| Coefficient Of Variation | 151.15 | |
| Mean Deviation | 254,089,548 | |
| Median | 41,367,000 | |
| Standard Deviation | 317,786,909 | |
| Sample Variance | 100988.5T | |
| Range | 935.4M | |
| R-Value | 0.71 | |
| Mean Square Error | 53669.1T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 50,573,166 | |
| Total Sum of Squares | 1413839.3T |
Fulgent Cash And Short Term Investments History
About Fulgent Genetics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Fulgent Genetics income statement, its balance sheet, and the statement of cash flows. Fulgent Genetics investors use historical funamental indicators, such as Fulgent Genetics's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Fulgent Genetics investors may use each financial statement separately, they are all related. The changes in Fulgent Genetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fulgent Genetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fulgent Genetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fulgent Genetics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 424.2 M | 312.5 M |
Pair Trading with Fulgent Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fulgent Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulgent Genetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Fulgent Stock
Moving against Fulgent Stock
| 0.38 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.38 | AVDL | Avadel Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Fulgent Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fulgent Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fulgent Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fulgent Genetics to buy it.
The correlation of Fulgent Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fulgent Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fulgent Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fulgent Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.